Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > Tirzepatide peptides RT | KL80 | | SM | High Quality Raw Peptide Tirzepatide peptides High Quality Peptide
Tirzepatide peptides RT | KL80 | | SM | High Quality Raw Peptide Tirzepatide peptides High Quality Peptide buy - large image1
Tirzepatide peptides RT | KL80 | | SM | High Quality Raw Peptide Tirzepatide peptides High Quality Peptide buy - image1
Tirzepatide peptides RT | KL80 | | SM | High Quality Raw Peptide Tirzepatide peptides High Quality Peptide buy - image2
Tirzepatide peptides RT | KL80 | | SM | High Quality Raw Peptide Tirzepatide peptides High Quality Peptide buy - image3
Tirzepatide peptides RT | KL80 | | SM | High Quality Raw Peptide Tirzepatide peptides High Quality Peptide buy - image4
Tirzepatide peptides RT | KL80 | | SM | High Quality Raw Peptide Tirzepatide peptides High Quality Peptide buy - image5
Tirzepatide peptides RT | KL80 | | SM | High Quality Raw Peptide Tirzepatide peptides High Quality Peptide buy - image6

Tirzepatide peptides RT | KL80 | | SM | High Quality Raw Peptide Tirzepatide peptides High Quality Peptide

COA TDS 2103 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Guangzhou

Brand:

Topi

Packaging:

20mg/10vials

Sample Available:

Yes

Price valid (until):

2026-08-28

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
3 days
Qualification:
Main Products:

peptides,Semagiutide,Retatrutide,GHK-CU,MOTS-c,Semax

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  



    Retatrutide (development code: LY3437943) is a next-generation, long-acting, triple agonist peptide developed for metabolic disorder research. It is a 39-amino acid synthetic peptide engineered to simultaneously activate three key metabolic receptors:

    - GLP-1R (Glucagon-like peptide-1 receptor)

    - GIPR (Glucose-dependent insulinotropic polypeptide receptor)

    - GCGR (Glucagon receptor)

    This unique trimodal mechanism offers superior potential for regulating body weight, glucose homeostasis, and lipid metabolism compared to single or dual agonist peptides. It stands out as the most potent weight-loss peptide in current metabolic research, with remarkable clinical efficacy far exceeding similar GLP-1 products.

    Key Features & Benefits

    - Triple-Receptor Agonism: Integrates appetite suppression (GLP-1), enhanced insulin sensitivity (GIP), and increased energy expenditure (Glucagon).

    - Powerful Weight Management: In clinical research, demonstrated mean weight reduction of up to 24.2% over 48 weeks.

    - Improved Metabolic Control: Effectively lowers blood glucose, regulates lipid profiles, reduces visceral fat and alleviates insulin resistance.

    - Extended Half-Life: Designed for once-weekly administration, ensuring convenient dosing and stable long-term experimental results.

    - High Purity & Stability: Available as white to off-white lyophilized powder with ≥99% HPLC purity, low endotoxin, stable structure and consistent batch quality.

    - Excellent Water Solubility: Quickly dissolved in sterile water and physiological buffer, easy to prepare and apply in animal experiments.

    Specifications

    - Appearance: White to off-white lyophilized powder

    - Purity: ≥99% (HPLC)

    - Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈

    - Molecular Weight: 4731.35 g/mol

    - Solubility: Soluble in water and aqueous buffers

    - Endotoxin: <0.1 EU/mg

    - Storage: Stable at -20℃ for 2 years; avoid repeated freeze-thaw cycles

    Advantages Compared With Similar Peptides

    Compared with Semaglutide and Tirzepatide, Retatrutide owns stronger fat-burning capacity, better hypoglycemic effect and milder side reactions. It accelerates basal metabolism while inhibiting excessive appetite, achieves synergistic weight loss and glucose regulation, and greatly improves overall metabolic health. It has broad application prospects in new drug research and development of obesity, diabetes and metabolic syndrome.

    Applications

    For research use only. Not for human or veterinary clinical use.
    Ideal for in vitro and in vivo studies investigating:

    - Obesity and long-term weight management

    - Type 2 diabetes mellitus and blood glucose regulation

    - Metabolic syndromes, dyslipidemia and NAFLD

    - Appetite regulation, satiety mechanism and energy metabolism pathway research

    - Pharmacokinetics, pharmacodynamics and preclinical drug evaluation

    Usage & Quality Control

    Reconstitute the lyophilized powder with sterile water or buffer to the desired concentration before use. For long-term storage, aliquot and keep at -80℃.
    Each batch undergoes strict full-process quality inspection, including mass spectrometry identification, purity detection, endotoxin test, stability test and homogeneity verification, to guarantee reliable repeatability of scientific research data.

    TB500 is a high-purity peptide used for tissue repair research. Product Detail

    TB500,  is a synthetic peptide widely used in advanced biochemical and pharmaceutical research. It is a naturally occurring peptide fragment that plays a significant role in cell migration, tissue regeneration, and repair processes. Due to its unique biological activity, TB500 has become a popular compound in laboratory studies focusing on wound healing, muscle recovery, inflammation control, and angiogenesis.

    This product is supplied as a high-purity white lyophilized powder with a purity level of ≥99%, ensuring consistency and reliability in experimental results. The freeze-dried form provides excellent stability during transportation and long-term storage. TB500 is easily reconstituted with bacteriostatic water or sterile saline, making it convenient for various laboratory applications.

    One of the key features of TB500 is its ability to promote cell differentiation and migration. It helps regulate actin, a protein essential for cell structure and movement, thereby enhancing tissue repair and regeneration processes. Researchers have shown interest in TB500 for its potential role in accelerating recovery from injuries, reducing inflammation, and improving flexibility in damaged tissues.

    TB500 is commonly applied in research areas such as tissue engineering, regenerative medicine, and anti-inflammatory studies. It has also been investigated for its role in cardiovascular repair and hair growth research due to its angiogenic properties. Additionally, TB500 is known for its systemic distribution in the body, which allows it to act on multiple tissues rather than being localized.

    Each vial contains 5mg of TB500, and each box includes 10 vials, making it suitable for bulk laboratory use. The product is manufactured under strict quality control standards to ensure high purity, stability, and batch-to-batch consistency.

    For optimal storage, TB500 should be kept refrigerated at 2–8°C. Once reconstituted, it is recommended to store the solution in a refrigerated environment and use it within a short period to maintain stability.

    Important: This product is strictly intended for research purposes only and is not approved for human or veterinary use. It must not be used for clinical treatment, diagnosis, or consumption.


     


    Pls input...

    Items Specifications

    Product Name TB500 / 
    Model BT5
    Specification 5mg × 10 vials / box
    Purity ≥99%
    Appearance White lyophilized powder
    Grade Research Grade
    Application For research use only
    Storage Store at 2–8°C, protected from light
    Package 1 box / 10 vials
    MOQ 10 boxes





    Shop TB500 BT5-Detailed Image 7
    Shop TB500 BT5-Detailed Image 8


    Shop TB500 BT5-Detailed Image 11



    Shop TB500 BT5-Detailed Image 15

    Shop TB500 BT5-Detailed Image 17



    Shop TB500 BT5-Detailed Image 21
    Shop TB500 BT5-Detailed Image 22
    Shop TB500 BT5-Detailed Image 23


      FAQ 


    Q1: About the after-sale service

    A: After purchasing the products from our Lab, we have A professional technical team and after-sales team to serve you and solve all your problems in the future


    Q2: Do you have stock?

    A: We understand most customers prefer stock, so we'll try to keep stock for most products. However, for some rare products, we won't keep stock and it needs time to synthesize.


    Q3: How do I start paying?

    Payment can be made by Bitcoin,wire transfer or paypal


    Q4: How to confirm product quality before placing an order?

    A: We got good feedback from customers and Tested by third-party institutions. You also can get free samples of some products. You just have to pay the shipping fee for the sample .

    You can send us your product specifications and requirements and we can customize for you.


    Q5: What is your MOQ?

    A: The minimum quantity we can order is 1 box.

    But usually we can accept a smaller quantity, say 100g, at the cost of 100% sample charge.


    Q6: Time for delivery?

    A: Leading time within 3 business days,Shipping time about 8-10 business days. 


    Q7: Why should I choose you?

    A: Powerful technical support-come from our highly skilled & fully experienced staff, working in chemical industry for over 5years, in average.Strict quality control-comes form our sophisticated management system.Professional and warm sales team-since we believe we can only win via our hard work in a competitive world.Quick response and excellent presale and after sale service-since we believe our customers deserve all the best service.

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates
    • Tirzepatide peptides RT | KL80 | | SM | High Quality Raw Peptide Tirzepatide peptides High Quality Peptide Certificates 2 TDS

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptides,Semagiutide,Retatrutide,GHK-CU,MOTS-c,Semax

    Location:

    Units 1503-14, 15th Floor, New HNA Building, No. 7 Guoxing Avenue, Lantian Subdistrict, Meilan District, Haikou City, Hainan Province

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    3 days

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    101-200

    Year of Establishment:

    2025

  • Inquiry History
    2103 Inquiries
    Country Product Purchase Quantity Date Posted
    Brazil

    Tirzepatide

    100 G Oct 28, 2026
    Belgium

    Tirzepatide

    10 MG Oct 28, 2026
    United States

    tirzepatide

    100 MG Oct 28, 2026
    United States

    Tirzepatide

    60 MG Oct 28, 2026
    United States

    Tirzepatide

    10 PCS Oct 28, 2026
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.